Race & Viral Resistance in Chronic Hepatitis C (VIRAHEP*
Race & Viral Resistance in Chronic Hepatitis C (VIRAHEP*
批准号:
6647205
负责人:
ROBERT S BROWN
金额:
$35.0万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-01 至 2006-04-30
关键词:
African American caucasian American chronic disease /disorder clinical trials combination chemotherapy fibrosis genotype hepatitis C hepatitis C virus human subject human therapy evaluation immunogenetics interferons liver disorder microorganism disease chemotherapy obesity pathologic process patient oriented research quality of life racial /ethnic difference ribavirin socioeconomics therapy compliance urban area virulence virus genetics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
The pathogenesis of hepatitis C (HCV) associated liver injury is poorly
understood. Studies of HCV pathogenesis have been impeded by the lack of an
animal model, the inability to maintain HCV in cell culture systems, and the
slow progression of disease, which hinders natural history studies. However,
though host and viral factors likely play a role in liver injury, neither has
been rigorously analyzed. Early studies suggest that viral clearance with acute
infection as well as with treatment is markedly decreased iin patients of
African American heritage. The reasons for this poor response are not
understood, but possibly relate to differences in demographics (e.g
socioeconomic status), comorbid conditions (e.g., obesity), genotype
distribution or virulence, viral kinetics, immune response, and compliance with
therapy. Previous studies have been limited by small sample size and referral
bias. Over the last 2 years, The Columbia-Cornell Liver Clinical Trials Network
has established an extended network of care that has performed clinical trials
including a large number of African Americans. This Network includes the
Columbia Presbyterian and Harlem Hospital Centers both within the Harlem
section of Manhattan and The New York-Cornell Center in central Manhattan.
Within this ethnically diverse population, we will answer several questions.
The primary hypothesis is that treatment response to PEGylated interferon and
ribavirin is decreased in African Americans. However, we postulate that most of
this decrease can be explained by differences in baseline characteristics and
non-biologic parameters, including body mass index, comorbid medical
conditions, socioeconomic status and the ability to complete therapy.
Additionally we will search for clinical predictors of response to therapy
including differences in immunogenetics and early viral kinetics. The secondary
hypothesis is that the progression of liver disease in African Americans is
comparable to that in a Caucasian American population after controlling for
potential confounders including the variables mentioned above and alcohol
consumption.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Strategies and Therapies for Outcomes Prevention in Cirrhosis: The STOP-C Liver Cirrhosis Network
-
批准号:10492742
-
项目类别:
-
资助金额:$57.44万
-
财政年份:2021
-
负责人:ROBERT S BROWN
-
依托单位:
Strategies and Therapies for Outcomes Prevention in Cirrhosis: The STOP-C Liver Cirrhosis Network
-
批准号:10311423
-
项目类别:
-
资助金额:$35.33万
-
财政年份:2021
-
负责人:ROBERT S BROWN
-
依托单位:
Strategies and Therapies for Outcomes Prevention in Cirrhosis: The STOP-C Liver Cirrhosis Network
-
批准号:10700170
-
项目类别:
-
资助金额:$62.28万
-
财政年份:2021
-
负责人:ROBERT S BROWN
-
依托单位:
Strategies and Therapies for Outcomes Prevention in Cirrhosis: The STOP-C Liver Cirrhosis Network
-
批准号:10690121
-
项目类别:
-
资助金额:$18.9万
-
财政年份:2021
-
负责人:ROBERT S BROWN
-
依托单位:
Race & Viral Resistance in Chronic Hepatitis C (VIRAHEP*
-
批准号:6407013
-
项目类别:
-
资助金额:$24.01万
-
财政年份:2001
-
负责人:ROBERT S BROWN
-
依托单位:
Race & Viral Resistance in Chronic Hepatitis C (VIRAHEP*
-
批准号:6765821
-
项目类别:
-
资助金额:$16.0万
-
财政年份:2001
-
负责人:ROBERT S BROWN
-
依托单位:
PEB IFN AND RIBAVIRIN VERSUS REBETRON IN HEPATITIS C
-
批准号:6567820
-
项目类别:
-
资助金额:$19.29万
-
财政年份:2001
-
负责人:ROBERT S BROWN
-
依托单位:
Race & Viral Resistance in Chronic Hepatitis C (VIRAHEP*
-
批准号:6896117
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2001
-
负责人:ROBERT S BROWN
-
依托单位:
ADEFOVIR DIPIVOXIL FOR PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION
-
批准号:6567828
-
项目类别:
-
资助金额:$19.29万
-
财政年份:2001
-
负责人:ROBERT S BROWN
-
依托单位:
Race & Viral Resistance in Chronic Hepatitis C (VIRAHEP*
-
批准号:6517968
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2001
-
负责人:ROBERT S BROWN
-
依托单位:
ADEFOVIR DIPIVOXIL FOR PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION
-
批准号:6468566
-
项目类别:
-
资助金额:$19.29万
-
财政年份:2000
-
负责人:ROBERT S BROWN
-
依托单位:
PEB IFN AND RIBAVIRIN VERSUS REBETRON IN HEPATITIS C
-
批准号:6468558
-
项目类别:
-
资助金额:$19.29万
-
财政年份:2000
-
负责人:ROBERT S BROWN
-
依托单位:
ORGAN ALLOCATION AND THE COST OF LIVER TRANSPLANTATION
-
批准号:2235640
-
项目类别:
-
资助金额:$3.38万
-
财政年份:1995
-
负责人:ROBERT S BROWN
-
依托单位:
EFFECT OF DIET SODIUM ON PLATELET FUNCTION AND PROSTAGLANDIN METABOLISM
-
批准号:4704166
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ROBERT S BROWN
-
依托单位:
METABOLIC STUDIES ON PATIENTS WITH NEPHROLITHIASIS
-
批准号:4704232
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ROBERT S BROWN
-
依托单位:
PHYSIOLOGY OF POTASSIUM REGULATION
-
批准号:4704213
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ROBERT S BROWN
-
依托单位:
EFFECT OF ASPIRIN AND INDOMETHACIN IN BARTTER'S SYNDROME
-
批准号:4704165
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ROBERT S BROWN
-
依托单位:
POTASSIUM REGULATION IN ANEPHRIC MAN
-
批准号:4704143
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ROBERT S BROWN
-
依托单位:
METABOLIC STUDIES ON PATIENTS WITH NEPHROLITHIASIS
-
批准号:4704144
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ROBERT S BROWN
-
依托单位:
EFFECT OF PROSTAGLANDIN INHIBITION ON NATRIURESIS OF HYPERTENSION
-
批准号:4704158
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ROBERT S BROWN
-
依托单位: